Adiponectin's beneficial actions are partially mediated by its capacity to promote healthy recruitment of new adipocytes (i.e. hyperplasia), increasing lipid buffering capacity in the context of obesity (Kim et al. 2007). The gene discussed is ADIPOQ; the disease is obesity disorder.